Variant report
Variant | nsv971333 |
---|---|
Chromosome Location | chr8:87028484-87029413 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-REXO1L2P-12 | chr8:87029048-87029355 | NONHSAT127544 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183619067 | chr8:87028491-87028492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564474397 | chr8:87028538-87028539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533036399 | chr8:87028543-87028544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565514095 | chr8:87028544-87028545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550087017 | chr8:87028566-87028567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569745542 | chr8:87028574-87028575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529111602 | chr8:87028635-87028636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187332127 | chr8:87028642-87028643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35123666 | chr8:87028656-87028657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371991241 | chr8:87028666-87028667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565411679 | chr8:87028698-87028699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563200648 | chr8:87028707-87028708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577195526 | chr8:87028712-87028713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557293246 | chr8:87028749-87028750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539734118 | chr8:87028755-87028756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs34185114 | chr8:87028796-87028797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376790081 | chr8:87028859-87028860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539741846 | chr8:87028860-87028861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556846201 | chr8:87028873-87028874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553432422 | chr8:87028874-87028875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577658094 | chr8:87028897-87028898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544824796 | chr8:87028902-87028903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191619398 | chr8:87028956-87028957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541545213 | chr8:87029001-87029002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564312710 | chr8:87029009-87029010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144783014 | chr8:87029010-87029011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533408069 | chr8:87029011-87029012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566857024 | chr8:87029016-87029017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543329204 | chr8:87029024-87029025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111429917 | chr8:87029025-87029026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529187145 | chr8:87029057-87029058 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs548724403 | chr8:87029069-87029070 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs565551589 | chr8:87029073-87029074 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs73269312 | chr8:87029093-87029094 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs118105206 | chr8:87029156-87029157 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs285409 | chr8:87029176-87029177 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs537084416 | chr8:87029217-87029218 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs550322228 | chr8:87029225-87029226 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs142888563 | chr8:87029253-87029254 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs117352155 | chr8:87029281-87029282 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs555957055 | chr8:87029314-87029315 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs116770314 | chr8:87029319-87029320 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs535116655 | chr8:87029322-87029323 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs558257519 | chr8:87029356-87029357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577941787 | chr8:87029359-87029360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543762454 | chr8:87029389-87029390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Autism | 20841430 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:87019600-87032200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:87020400-87029600 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr8:87020800-87029000 | Weak transcription | Brain Substantia Nigra | brain |
4 | chr8:87024200-87029200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr8:87024600-87029800 | Weak transcription | Brain Angular Gyrus | brain |
6 | chr8:87024800-87029200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
7 | chr8:87024800-87029600 | Weak transcription | Brain Hippocampus Middle | brain |
8 | chr8:87026600-87031000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr8:87028800-87029200 | Enhancers | Fetal Brain Female | brain |
10 | chr8:87028800-87030800 | Enhancers | Brain Germinal Matrix | brain |
11 | chr8:87029000-87030400 | Enhancers | Brain Substantia Nigra | brain |
12 | chr8:87029000-87030800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
13 | chr8:87029200-87029600 | Weak transcription | Fetal Brain Female | brain |
14 | chr8:87029200-87030200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr8:87029200-87030200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |